0102030405
CINACALCET HYDROCHLORIDE CAS No. 364782-34-3 Pharmaceutical Intermediates
02
introduction
Cinacalcet Hydrochloride is a calcimimetic agent that plays a crucial role in the management of calcium levels in the body.
It works by increasing the sensitivity of the calcium-sensing receptors on parathyroid cells, leading to a decrease in parathyroid hormone (PTH) secretion.
This mechanism makes it particularly effective in treating conditions associated with elevated PTH levels, such as secondary hyperparathyroidism in patients with chronic kidney disease and hypercalcemia in patients with parathyroid carcinoma.
It works by increasing the sensitivity of the calcium-sensing receptors on parathyroid cells, leading to a decrease in parathyroid hormone (PTH) secretion.
This mechanism makes it particularly effective in treating conditions associated with elevated PTH levels, such as secondary hyperparathyroidism in patients with chronic kidney disease and hypercalcemia in patients with parathyroid carcinoma.
02
Physical and chemical properties
- Solubility: Cinacalcet Hydrochloride is soluble in water and organic solvents, facilitating its formulation into tablets and ensuring rapid absorption in the gastrointestinal tract.
- Stability: The compound exhibits excellent chemical stability under standard storage conditions, ensuring a longer shelf life and reliability in pharmaceutical applications.
These properties not only enhance the efficacy of Cinacalcet Hydrochloride in clinical settings but also contribute to its overall safety profile.
- Stability: The compound exhibits excellent chemical stability under standard storage conditions, ensuring a longer shelf life and reliability in pharmaceutical applications.
These properties not only enhance the efficacy of Cinacalcet Hydrochloride in clinical settings but also contribute to its overall safety profile.
1. Effective Management of Hyperparathyroidism: Cinacalcet Hydrochloride is highly effective in reducing elevated PTH levels, making it a vital treatment option for patients with chronic kidney disease and parathyroid carcinoma.
2. Convenient Oral Administration: Available in tablet form, Cinacalcet Hydrochloride offers a convenient route of administration, improving patient compliance and ease of use.
3. Minimal Side Effects: Compared to other treatments for hyperparathyroidism, Cinacalcet Hydrochloride has a favorable side effect profile, making it a safer option for long-term management.
4. Regulatory Compliance: Our Cinacalcet Hydrochloride products adhere to all relevant regulatory standards, ensuring they are suitable for use in pharmaceutical applications worldwide.
5. Versatile Applications: In addition to its primary uses, Cinacalcet Hydrochloride may also be beneficial in other conditions related to calcium metabolism, expanding its potential applications in clinical practice.
2. Convenient Oral Administration: Available in tablet form, Cinacalcet Hydrochloride offers a convenient route of administration, improving patient compliance and ease of use.
3. Minimal Side Effects: Compared to other treatments for hyperparathyroidism, Cinacalcet Hydrochloride has a favorable side effect profile, making it a safer option for long-term management.
4. Regulatory Compliance: Our Cinacalcet Hydrochloride products adhere to all relevant regulatory standards, ensuring they are suitable for use in pharmaceutical applications worldwide.
5. Versatile Applications: In addition to its primary uses, Cinacalcet Hydrochloride may also be beneficial in other conditions related to calcium metabolism, expanding its potential applications in clinical practice.
In addition to our high-quality Cinacalcet Hydrochloride, we also provide a range of laboratory equipment and supplies essential for pharmaceutical research and development. Our offerings include:
- High-Performance Liquid Chromatography (HPLC) Systems: Ideal for analyzing the purity and composition of pharmaceutical compounds, including Cinacalcet Hydrochloride.
- Mass Spectrometry (MS) Instruments: Essential for determining molecular weights and structural information of active pharmaceutical ingredients (APIs).
- Reagents and Solvents: A comprehensive selection of high-purity reagents and solvents to support various chemical reactions and analyses.
- High-Performance Liquid Chromatography (HPLC) Systems: Ideal for analyzing the purity and composition of pharmaceutical compounds, including Cinacalcet Hydrochloride.
- Mass Spectrometry (MS) Instruments: Essential for determining molecular weights and structural information of active pharmaceutical ingredients (APIs).
- Reagents and Solvents: A comprehensive selection of high-purity reagents and solvents to support various chemical reactions and analyses.
In conclusion, the Cinacalcet Hydrochloride is a vital compound for laboratories engaged in pharmaceutical and microbiological research. Its high purity, stability, and versatility make it an essential reagent for scientists seeking to advance their understanding of antibiotic mechanisms and resistance.
As a leading foreign trade company, we are committed to providing our clients with top-quality products and unparalleled support, ensuring that they can achieve their research goals efficiently and effectively.
Choosing our Cinacalcet Hydrochloride means partnering with a reliable supplier committed to quality, efficiency, and customer satisfaction.
Contact us today to learn more about how our Cinacalcet Hydrochloride can enhance your drug development processes and contribute to your success in the pharmaceutical market.
As a leading foreign trade company, we are committed to providing our clients with top-quality products and unparalleled support, ensuring that they can achieve their research goals efficiently and effectively.
Choosing our Cinacalcet Hydrochloride means partnering with a reliable supplier committed to quality, efficiency, and customer satisfaction.
Contact us today to learn more about how our Cinacalcet Hydrochloride can enhance your drug development processes and contribute to your success in the pharmaceutical market.


